Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasms

A non-myeloablative regimen of fludarabine and 200 cGy total body irradiation combined with post-grafting immunosuppression with mycophenolate mofetil and a calcineurin inhibitor facilitates allogeneic hematopoietic cell transplantation from HLA-matched related or unrelated donors in older patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Monaco, Federico, Scott, Bart L., Chauncey, Thomas R., Petersen, Finn B., Storer, Barry E., Baron, Frederic, Flowers, Mary E., Deeg, H. Joachim, Maloney, David G., Storb, Rainer, Sandmaier, Brenda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545836/
https://www.ncbi.nlm.nih.gov/pubmed/30630975
http://dx.doi.org/10.3324/haematol.2018.199398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545836/
https://www.ncbi.nlm.nih.gov/pubmed/30630975
http://dx.doi.org/10.3324/haematol.2018.199398

Ejemplares similares